Doctorglasses Chain Co

Doctorglasses Chain Co EBIT CAGR 5Y

The EBIT CAGR (5 Year) of Doctorglasses Chain Co (300622.SZ) as of Nov 11, 2026 is 18.12 %. In the previous year, EBIT CAGR (5 Year) was 18.12 % — a change of 0.00% (lower).

EBIT CAGR 5Y

18.12 %

YoY

0.00%

Last updated:

EBIT CAGR (5 Year) of Doctorglasses Chain Co is 2025 18.12 % . EBIT CAGR (5 Year) of Doctorglasses Chain Co was 2024 18.12 % . It decreases by 0.00% lower compared to the previous year.

The Doctorglasses Chain Co EBIT CAGR 5Y history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT CAGR 5Y
Date
EBIT CAGR 5Y
Jan 1, 2018
18.12 CNY
Jan 1, 2019
18.12 CNY
Jan 1, 2020
18.12 CNY
Jan 1, 2021
18.12 CNY
Jan 1, 2022
18.12 CNY
Jan 1, 2023
18.12 CNY
Jan 1, 2024
18.12 CNY
Jan 1, 2025
18.12 CNY
The Doctorglasses Chain Co EBIT CAGR 5Y history
YEAREBIT CAGR 5YYoY
18.12 %0.00%
18.12 %0.00%
18.12 %0.00%
18.12 %0.00%
18.12 %0.00%
18.12 %0.00%
18.12 %0.00%
18.12 %0.00%
18.12 %0.00%
18.12 %0.00%
18.12 %0.00%
18.12 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Doctorglasses Chain Co Stock analysis

What does Doctorglasses Chain Co do? Doctorglasses Chain Co., Ltd. generates revenue through its chain of optical retail stores offering frames, lenses, sunglasses, reading glasses, contact lenses, and care solutions, alongside optometry and optics services. The company operates under the brands President optical, Doctor’s Glasses, zele, and Tong, selling products via direct stores, e-commerce, and wholesale channels. Its primary customer segments include individuals seeking eyewear solutions and optometry services, with a focus on retail and online sales channels. The firm’s product portfolio spans prescription and non-prescription eyewear, including specialized options like reading glasses and contact lenses, supported by care solutions for lens maintenance. Brands such as President optical and Doctor’s Glasses target diverse consumer segments, while zele and Tong cater to specific market niches. Sales through direct stores and e-commerce platforms drive the majority of revenue, complemented by wholesale distribution to other retailers. Doctorglasses Chain Co., Ltd. serves both individual consumers and business clients through its retail and wholesale models. The company’s revenue streams are derived from the sale of eyewear products and associated services, with a strong emphasis on brand-specific product lines. Direct store sales and e-commerce represent the most significant distribution channels, ensuring broad market coverage across its operational regions. Doctorglasses Chain Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Doctorglasses Chain Co stock

EBIT CAGR (5 Year) of Doctorglasses Chain Co is 18.12 % in 2025.

On Eulerpool you can find the complete historical development of EBIT CAGR (5 Year) Doctorglasses Chain Co since 2006 – with annual values, charts, and detailed analysis.

The 5-year EBIT CAGR shows the compound annual growth rate of EBIT over the past five years.

To evaluate EBIT CAGR (5 Year)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT CAGR (5 Year).

EBIT CAGR (5 Year)'s is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT CAGR (5 Year)'s Doctorglasses Chain Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Doctorglasses Chain Co

All Key Metrics — Doctorglasses Chain Co